Market Overview
The coronary heart disease diagnostic imaging market covers technologies that enable clinicians to visualize coronary arteries and assess blood flow without invasive procedures. This segment includes computed tomography angiography, cardiac magnetic resonance imaging, stress echocardiography, and nuclear perfusion imaging systems. The market's $3.06 billion valuation reflects growing clinical adoption of these technologies as first-line diagnostic tools.
- •Encompasses CT, MRI, ultrasound, and nuclear imaging devices for coronary assessment
- •Market size estimated at $3.06 billion for 2025 based on industry analyst projections
- •Growth trajectory supported by shift toward non-invasive diagnostic approaches
Growth Drivers
Rising global prevalence of coronary artery disease, particularly among aging demographics, directly increases demand for diagnostic imaging services. Technological improvements in image resolution, scan speed, and radiation dose reduction make these modalities more attractive to clinicians and patients. Expanding healthcare access in developing regions and increasing awareness of preventive cardiology further stimulate market expansion.
- •Aging global population increases incidence of coronary heart disease requiring diagnosis
- •Advances in imaging technology improve diagnostic accuracy and patient comfort
- •Growing preference for non-invasive testing over traditional catheterization procedures
Segmentation and Regional Analysis
The market spans multiple imaging modalities, with computed tomography angiography representing the largest segment due to its speed and widespread availability. North America currently leads in market share, supported by advanced healthcare infrastructure and high disease prevalence. Asia-Pacific emerges as the fastest-growing region, driven by economic development, improving medical facilities, and rising cardiovascular disease burden in countries like China and India.
- •CT angiography dominates, followed by MRI and echocardiography systems
- •North America holds largest share, with Europe and Asia-Pacific following
- •Emerging markets show accelerated growth due to healthcare infrastructure expansion
Trends and Outlook
What are the recent trends and outlook?
Artificial intelligence integration for automated image analysis and interpretation represents a significant trend, potentially improving diagnostic speed and consistency. The market is moving toward hybrid imaging systems combining multiple modalities and toward more compact, accessible equipment suitable for diverse clinical settings. Future growth will likely emphasize value-based care models, where imaging technology must demonstrate clear clinical and economic benefits to achieve widespread adoption.
- •AI-powered imaging analysis tools enhance diagnostic workflow and accuracy
- •Hybrid imaging systems combining multiple modalities gain clinical traction
- •Market evolution toward point-of-care and compact imaging solutions
Get in touch and our analysts will be happy to help with custom market sizing, deeper segmentation, supplier detail or a bespoke study built for you.
Connect to an analyst →Market size and forecast are Claight Analysis, informed by public research and industry data. Historical years before 2025 and all forecast years are Claight estimates at the stated CAGR. Retrieved 2026.